Yuki Muroyama

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Locally Advanced

Surgical Site Infection

Neoadjuvant Chemotherapy

Top Venues

Clinical case reports

Journal of immunology (Baltimore, Md. : 1950)

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Yuki Muroyama, Chihiro Inoue, Fumiyoshi Fujishima, Shogo Shigeta, Junko Hasegawa-Minato, Muneaki Shimada, Takashi Suzuki
ExcLAMation marks in a pelvic lymph node. Clinical case reports 11 (12) (2023)
Yuki Muroyama, Chihiro Inoue, Fumiyoshi Fujishima, Shogo Shigeta, Junko Hasegawa-Minato, Muneaki Shimada, Takashi Suzuki
ExcLAMation marks in a pelvic lymph node. Clinical case reports 11 (12) (2023)
Jonathan B Johnnidis, Yuki Muroyama, Shin Foong Ngiow, Zeyu Chen, Sasikanth Manne, Zhangying Cai, Shufei Song, Jesse M Platt, Jason M Schenkel, Mohamed S Abdel Hakeem, Jean-Christophe Beltra, Allison R Greenplate, Mohammed-Alkhatim A Ali, Kito Nzingha, Josephine R Giles, Christelle Harly, John Attanasio, Kristen E Pauken, Bertram Bengsch, Michael A Paley, Vesselin T Tomov, Makoto Kurachi, Dario A A Vignali, Arlene H Sharpe, Steven L Reiner, Avinash Bhandoola, F Bradley Johnson, E John Wherry
Inhibitory signaling sustains a distinct early memory CD8+ T cell precursor that is resistant to DNA damage. Science immunology 6 (55) (2022)
Martin W LaFleur, Yuki Muroyama, Charles G Drake, Arlene H Sharpe
Inhibitors of the PD-1 Pathway in Tumor Therapy. Journal of immunology (Baltimore, Md. : 1950) 200 (2) (2018)